4.8 Article

Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD)

Related references

Note: Only part of the references are listed.
Review Neurosciences

Molecular and Cellular Mechanisms of Rapid-Acting Antidepressants Ketamine and Scopolamine

Eric S. Wohleb et al.

CURRENT NEUROPHARMACOLOGY (2017)

Article Clinical Neurology

Reliability and validity of the Symptoms of Depression Questionnaire (SDQ)

Paola Pedrelli et al.

CNS SPECTRUMS (2014)

Article Psychiatry

The role and interpretation of pilot studies in clinical research

Andrew C. Leon et al.

JOURNAL OF PSYCHIATRIC RESEARCH (2011)

Article Pharmacology & Pharmacy

Two-Year Outcome of Vagus Nerve Stimulation in Treatment-Resistant Depression

Malek Bajbouj et al.

JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2010)

Review Behavioral Sciences

A Review of Continuation Electroconvulsive Therapy Application, Safety, and Efficacy

Kenneth Trevino et al.

JOURNAL OF ECT (2010)

Article Neurosciences

Diagnosis and definition of treatment-resistant depression

M Fava

BIOLOGICAL PSYCHIATRY (2003)